Sublocade (buprenorphine) is a brand-name extended-release injection that’s prescribed for opioid use disorder. Sublocade has interactions with alcohol, some other drugs, and certain supplements.

If you’re considering treatment for opioid use disorder (OUD), your doctor may recommend Sublocade. It’s prescribed as part of a complete treatment program to manage opioid addiction in adults with ...

Sublocade (buprenorphine) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved it to treat opioid use disorder in adults, as part of a complete treatment ...

Sublocade (buprenorphine) is a prescription drug that’s used to treat opioid use disorder. Sublocade can cause side effects that range from mild to serious. Examples include injection site reaction, ...

The Food & Drug Administration (FDA) announced its approval of an injectable form of buprenorphine (brand name: Sublocade), a medication used to treat opiate addiction. Sublocade releases a steady ...

RICHMOND, Va., Oct. 15, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) this week published compelling results from a multicenter, open-label clinical trial published in JAMA Network Open. Two ...

Alberta to provide new opioid treatment for free As opioid-related 911 calls spike in the province, a new opioid treatment is being offered free of charge to help people survive drug addiction.

RICHMOND, Va. - Indivior PLC (NASDAQ:LSE: INDV), a pharmaceutical company, has shared research findings emphasizing the efficacy and safety of its medication, SUBLOCADE, for individuals recovering ...

Indivior recently released results from a multicenter, open-label clinical trial showing that rapid induction with SUBLOCADE, using a single 4 mg oral buprenorphine dose followed by a same-day ...

Monthly injections of Sublocade are proving to be a new life changing treatment for fentanyl addicts. NBC News’ Dash Burns spoke with a Sublocade user who explained ...

An injectable opioid treatment drug used to provide stabilization, reduce cravings, and potentially block overdoses is now fully funded in Alberta. The announcement for the drug, made by associate ...